News Quantified

JAGX – jaguar health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Jaguar Animal Health (NASDAQ:JAGX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Jaguar Animal Health (NASDAQ:JAGX) was downgraded by analysts at Wall St

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi [Yahoo! Finance]

Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication [Yahoo! Finance]

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs [Yahoo! Finance]

Form 8-K Jaguar Health, Inc. For: Jan 16

Form 4 Jaguar Health, Inc. For: Dec 11 Filed by: King Steven R.

Form 4 Jaguar Health, Inc. For: Dec 11 Filed by: CONTE LISA A

Form 4 Jaguar Health, Inc. For: Dec 11 Filed by: Wolin Jonathan S.

Form 8-K Jaguar Health, Inc. For: Jan 12

Top News Gainers

6/11 Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication 35.0%

10/30 Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc. 28.6%

11/12 Jaguar Health to Host Investor Call Nov. 14th at 9 a.m. Eastern Regarding Interim Analysis of HALT-D Study of Mytesi (Crofelemer) for Prevention of Diarrhea in Breast Cancer Patients, Q3 Financials & Business Updates 25.7%

12/31 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 17.8%

9/30 Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Application 12.0%

9/12 Jaguar Health Inc (NASDAQ: JAGX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock. 10.8%

8/20 Form 3 Jaguar Health, Inc. For: Aug 13 Filed by: Lizak Carol R. 10.3%

6/24 Jaguar Health Regains Compliance with All Applicable Nasdaq Stock Market Listing Standards 9.5%

9/16 Jaguar Health's Mytesi Drug Product Now Approved for Sale in Puerto Rico 8.3%

12/26 Form 8-K Jaguar Health, Inc. For: Dec 20 6.9%

Top News Decliners

11/14 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -28.8%

4/16 Form 8-K Jaguar Health, Inc. For: Apr 15 -22.1%

8/14 Form 10-Q Jaguar Health, Inc. For: Jun 30 -20.9%

6/6 Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split -19.0%

3/23 Form 8-K Jaguar Health, Inc. For: Mar 21 -19.0%

7/5 Form FWP Jaguar Health, Inc. Filed by: Jaguar Health, Inc. -15.1%

9/24 Form 8-K Jaguar Health, Inc. For: Sep 24 -12.9%

5/11 Jaguar Health readies $10M equity offering [Seeking Alpha] -12.6%

7/15 Form S-1/A Jaguar Health, Inc. -12.4%

10/1 Jaguar Health Files Final Canalevia (Crofelemer) Technical Section for Proposed Indication of Chemotherapy-Induced Diarrhea in Dogs -12.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day